Protalix BioTherapeutics Inc (PLX)
1.08
+0.07
(+6.93%)
USD |
NYAM |
Oct 04, 16:00
1.06
-0.02
(-1.85%)
After-Hours: 20:00
Protalix BioTherapeutics Shareholders Equity (Annual): 33.57M for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 33.57M |
| December 31, 2022 | -10.64M |
| December 31, 2021 | -6.036M |
| December 31, 2020 | -27.04M |
| December 31, 2019 | -70.32M |
| December 31, 2018 | -52.88M |
| December 31, 2017 | -29.46M |
| December 31, 2016 | -9.957M |
| December 31, 2015 | 10.87M |
| December 31, 2014 | -55.60M |
| December 31, 2013 | -26.95M |
| December 31, 2012 | -3.357M |
| December 31, 2011 | -26.08M |
| December 31, 2010 | -11.32M |
| Date | Value |
|---|---|
| December 31, 2009 | 15.88M |
| December 31, 2008 | 44.35M |
| December 31, 2007 | 63.68M |
| December 31, 2006 | 24.28M |
| December 31, 2005 | 6.095M |
| December 31, 2004 | 0.495M |
| December 31, 2003 | 0.6554M |
| December 31, 2002 | 0.7961M |
| December 31, 2001 | 0.9459M |
| December 31, 2000 | 1.344M |
| December 31, 1999 | 1.589M |
| December 31, 1998 | 3.355M |
| December 31, 1997 | 0.00 |
| December 31, 1996 | 0.00 |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
-70.32M
Minimum
2019
33.57M
Maximum
2023
-16.09M
Average
-10.64M
Median
2022
Shareholders Equity (Annual) Benchmarks
| Aethlon Medical Inc | 5.766M |
| Predictive Oncology Inc | 8.272M |
| bluebird bio Inc | 194.54M |
| AIM ImmunoTech Inc | 10.23M |
| Armata Pharmaceuticals Inc | -32.06M |